Oncotarget Trending With Impact: Adjunct Virotherapy Fights Multiple Myeloma Researchers investigated using oncolytic viruses to treat multiple myeloma—alone and in a combination approach.... read more March 17, 2022
Oncotarget A Remote Weight Loss Strategy for Breast Cancer Survivors Researchers Jennifer Y. Sheng and Vered Stearns discussed the results of a study that compared... read more March 9, 2022
Oncotarget Trending With Impact: Are NOTCH1 Variants Prognostic in Breast Cancer? Researchers determined the prognostic ability of three NOTCH1 gene variants by incorporating them into two... read more February 24, 2022
Oncotarget Trending With Impact: New Pre-Transplant AML Treatment Combinations Researchers aimed to improve acute myeloid leukemia (AML) patient outcomes after allo-HSCT with new pre-transplant... read more February 17, 2022
Oncotarget Iron Chelators in Cancer Treatment In a review paper published in Oncotarget in 2021, researchers discuss the impact of iron... read more February 10, 2022
Oncotarget Trending With Impact: What Causes Chemo Brain? Researchers investigated potential therapeutic culprits of “chemo brain” in a trending new paper published by... read more January 28, 2022
Oncotarget Oncotarget’s Top 10 Most-Viewed Papers in 2021 Read the 10 most-viewed oncology-focussed papers on Oncotarget.com in 2021.—#10: Metformin and... read more January 21, 2022
Oncotarget Can Purified Cholera Stop Obesity? In this 2019 study, researchers investigated the effects of purified elements of cholera toxin in... read more December 31, 2021
Oncotarget New Study: Biomarkers Linked to the Progression of Endometrial Cancer Researchers conducted a study to identify differentially regulated signaling pathways and genes related to endometrial... read more December 22, 2021
Oncotarget Could Metformin and Rapamycin Replace Maintenance Chemotherapy? Researchers explored metformin with or without rapamycin as maintenance therapy in patients with metastatic pancreatic... read more December 16, 2021